Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ddo | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DDO mRNA] | CTD | PMID:31150632 | Ddo | Rat | 17beta-estradiol | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | Estradiol results in decreased expression of DDO mRNA | CTD | PMID:19484750|PMID:39298647 | Ddo | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ddo (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of DDO mRNA | CTD | PMID:21570461 | Ddo | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DDO mRNA | CTD | PMID:19770486 | Ddo | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Ddo (Mus musculus) | 6480464 | bisphenol S results in increased expression of DDO mRNA | CTD | PMID:30951980 | Ddo | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | bisphenol S results in decreased expression of DDO mRNA | CTD | PMID:39298647 | Ddo | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | Ddo (Mus musculus) | 6480464 | Decitabine results in increased expression of DDO mRNA | CTD | PMID:26961959 | Ddo | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of DDO mRNA | CTD | PMID:28959563 | Ddo | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DDO mRNA | CTD | PMID:35163327 | Ddo | Rat | aristolochic acid A | increases expression | ISO | DDO (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of DDO mRNA | CTD | PMID:33212167 | Ddo | Rat | benzo[a]pyrene | multiple interactions | ISO | Ddo (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DDO mRNA] | CTD | PMID:22228805 | Ddo | Rat | benzo[a]pyrene | increases methylation | ISO | DDO (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of DDO promoter | CTD | PMID:27901495 | Ddo | Rat | benzo[a]pyrene | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of DDO mRNA | CTD | PMID:22228805 | Ddo | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DDO mRNA | CTD | PMID:25181051 | Ddo | Rat | bisphenol A | increases expression | ISO | Ddo (Mus musculus) | 6480464 | bisphenol A results in increased expression of DDO mRNA | CTD | PMID:32156529 | Ddo | Rat | bisphenol F | increases expression | ISO | Ddo (Mus musculus) | 6480464 | bisphenol F results in increased expression of DDO mRNA | CTD | PMID:30951980 | Ddo | Rat | buta-1,3-diene | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | 1,3-butadiene results in decreased expression of DDO mRNA | CTD | PMID:29038090 | Ddo | Rat | cadmium atom | multiple interactions | ISO | Ddo (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDO more ... | CTD | PMID:37236586 | Ddo | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of DDO mRNA | CTD | PMID:33453195 | Ddo | Rat | cadmium dichloride | multiple interactions | ISO | Ddo (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDO more ... | CTD | PMID:37236586 | Ddo | Rat | calcium silicate | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | calcium silicate results in decreased expression of DDO mRNA | CTD | PMID:29279043 | Ddo | Rat | carbon nanotube | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of DDO mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681|PMID:25620056 | Ddo | Rat | CGP 52608 | multiple interactions | ISO | DDO (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to DDO gene] | CTD | PMID:28238834 | Ddo | Rat | copper(II) sulfate | decreases expression | ISO | DDO (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of DDO mRNA | CTD | PMID:19549813 | Ddo | Rat | D-aspartic acid | affects abundance | ISO | Ddo (Mus musculus) | 6480464 | DDO protein affects the abundance of D-Aspartic Acid | CTD | PMID:16516413|PMID:16525061|PMID:16725213|PMID:18842900|PMID:26961959 | Ddo | Rat | D-aspartic acid | increases metabolic processing | ISO | Ddo (Mus musculus) | 6480464 | DDO protein results in increased metabolism of D-Aspartic Acid | CTD | PMID:32185508 | Ddo | Rat | D-aspartic acid | increases degradation | EXP | | 6480464 | DDO protein results in increased degradation of D-Aspartic Acid | CTD | PMID:32376478 | Ddo | Rat | dibenz[a,h]anthracene | increases expression | ISO | Ddo (Mus musculus) | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of DDO mRNA | CTD | PMID:26377693 | Ddo | Rat | dicrotophos | decreases expression | ISO | DDO (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of DDO mRNA | CTD | PMID:28302478 | Ddo | Rat | epoxiconazole | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of DDO mRNA | CTD | PMID:35436446 | Ddo | Rat | ethanol | increases expression | ISO | Ddo (Mus musculus) | 6480464 | Ethanol results in increased expression of DDO mRNA | CTD | PMID:30319688 | Ddo | Rat | ethyl methanesulfonate | increases expression | ISO | DDO (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of DDO mRNA | CTD | PMID:23649840 | Ddo | Rat | fonofos | increases methylation | ISO | DDO (Homo sapiens) | 6480464 | Fonofos results in increased methylation of DDO promoter | CTD | PMID:22847954 | Ddo | Rat | formaldehyde | increases expression | ISO | DDO (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of DDO mRNA | CTD | PMID:23649840 | Ddo | Rat | isotretinoin | decreases expression | ISO | DDO (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of DDO mRNA | CTD | PMID:20436886 | Ddo | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of DDO gene | CTD | PMID:35440735 | Ddo | Rat | methyl methanesulfonate | increases expression | ISO | DDO (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of DDO mRNA | CTD | PMID:23649840 | Ddo | Rat | Monobutylphthalate | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | monobutyl phthalate results in decreased expression of DDO mRNA | CTD | PMID:35278568 | Ddo | Rat | N-methyl-D-aspartic acid | affects abundance | ISO | Ddo (Mus musculus) | 6480464 | DDO protein affects the abundance of N-Methylaspartate | CTD | PMID:16516413 | Ddo | Rat | nickel sulfate | increases expression | ISO | DDO (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of DDO mRNA | CTD | PMID:22714537 | Ddo | Rat | okadaic acid | decreases expression | ISO | DDO (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of DDO mRNA | CTD | PMID:38832940 | Ddo | Rat | paracetamol | affects expression | ISO | Ddo (Mus musculus) | 6480464 | Acetaminophen affects the expression of DDO mRNA | CTD | PMID:17562736 | Ddo | Rat | paracetamol | decreases expression | ISO | DDO (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of DDO mRNA | CTD | PMID:29067470 | Ddo | Rat | parathion | increases methylation | ISO | DDO (Homo sapiens) | 6480464 | Parathion results in increased methylation of DDO promoter | CTD | PMID:22847954 | Ddo | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ddo (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of DDO mRNA | CTD | PMID:36331819 | Ddo | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DDO mRNA | CTD | PMID:35163327 | Ddo | Rat | phencyclidine | multiple interactions | ISO | Ddo (Mus musculus) | 6480464 | [DDO protein affects the susceptibility to Phencyclidine] which affects the expression of DLG4 mRNA; [DDO more ... | CTD | PMID:25979765 | Ddo | Rat | phencyclidine | affects response to substance | ISO | Ddo (Mus musculus) | 6480464 | DDO protein affects the susceptibility to Phencyclidine | CTD | PMID:25979765 | Ddo | Rat | phenobarbital | affects expression | ISO | Ddo (Mus musculus) | 6480464 | Phenobarbital affects the expression of DDO mRNA | CTD | PMID:23091169 | Ddo | Rat | pirinixic acid | multiple interactions | ISO | DDO (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Ddo | Rat | propanal | decreases expression | ISO | DDO (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of DDO mRNA | CTD | PMID:26079696 | Ddo | Rat | S-nitrosoglutathione | increases expression | ISO | DDO (Homo sapiens) | 6480464 | S-Nitrosoglutathione results in increased expression of DDO mRNA | CTD | PMID:38825487 | Ddo | Rat | terbufos | increases methylation | ISO | DDO (Homo sapiens) | 6480464 | terbufos results in increased methylation of DDO promoter | CTD | PMID:22847954 | Ddo | Rat | tetrachloromethane | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of DDO mRNA | CTD | PMID:27339419|PMID:31919559 | Ddo | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DDO mRNA] | CTD | PMID:31150632 | Ddo | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of DDO mRNA | CTD | PMID:31150632 | Ddo | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of DDO mRNA | CTD | PMID:34492290 | Ddo | Rat | titanium dioxide | decreases expression | ISO | Ddo (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of DDO mRNA | CTD | PMID:23557971 | Ddo | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of DDO mRNA | CTD | PMID:33387578 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















